Batu Biologics

About:

Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing

Website: http://www.batubiologics.com/

Twitter/X: batubiologics

Description:

Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therepies in the area of immune modulation. Our products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its two flagship products: Immstem and Vallovax. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its IP

Total Funding Amount:

$2.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2013-01-01

Contact Email:

dimitri.theo(AT)batubiologics.com

Founders:

Dimitri Theofilopoulos, Thomas Ichim

Number of Employees:

1-10

Last Funding Date:

2017-12-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai